Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 05, 2015 8:48 AM ET

Biotechnology

Company Overview of Inovio Pharmaceuticals, Inc.

Executive Profile

Philip D. Greenberg M.D.

Member of Scientific Advisory Board, Inovio Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 8 different industries.

See Board Relationships
----

Background

Dr. Philip D. Greenberg, M.D. serves as Head of Program in Immunology at Fred Hutchinson Cancer Research Center. Dr. Greenberg served as Director of the Immunology Program at FHCRC and Co-Director of the Immunology Program for UW Center for AIDS Research since 1988. He joined FHCRC and the Division of Oncology at University of Washington in 1976. He has been a Member of Scientific Advisory Board at Inovio Pharmaceuticals, Inc. since September 2011. Dr. Greenberg serves ...

Corporate Headquarters

660 West Germantown Pike
Plymouth Meeting, Pennsylvania 19462

United States

Phone: 267-440-4200
Fax: 267-440-4242

Board Members Memberships

Director

Education

MD 1971
State University of New York
Unknown/Other Education
Washington University, St. Louis
Post-Doctoral Training
University of California - San Diego

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$821.0K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$517.2K
Kalevi Reijonen M.D.Chief Executive Officer and President
FIT Biotech Oy
--
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$398.8K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$393.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Inovio Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.